Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT

BackgroundThis study compared manually delineated gross tumour volume (GTV) and automatically generated biological tumour volume (BTV) based on fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT to assess the robustness of predefined PET algorithms for radiotherapy (RT) planning in routine clinical practice.MethodsRT-planning data from 20 consecutive patients (lung- (40%), oesophageal- (25%), gynaecological- (25%) and colorectal (10%) cancer) who had undergone FDG-PET/CT planning between 08/2010 and 09/2011 were retrospectively analysed, five of them underwent neoadjuvant chemotherapy before radiotherapy. In addition to manual GTV contouring, automated segmentation algorithms were applied–among these 38%, 42%, 47% and 50% SUVmax as well as the PERCIST total lesion glycolysis (TLG) algorithm. Different ratios were calculated to assess the overlap of GTV and BTV including the conformity index and the ratio GTV included within the BTV.ResultsMedian age of the patients was 66 years and median tumour SUVmax 9.2. Median size of the GTVs defined by the radiation oncologist was 43.7 ml. Median conformity indices were between 30.0–37.8%. The highest amount of BTV within GTV was seen with the 38% SUVmax algorithm (49.0%), the lowest with 50% SUVmax (36.0%). Best agreement was obtained for oesophageal cancer patients with a conformity index of 56.4% and BTV within GTV ratio of 71.1%.ConclusionsAt present there is only low concordance between manually derived GTVs and automatically segmented FDG-PET/CT based BTVs indicating the need for further research in order to achieve higher volumetric conformity and therefore to get access to the full potential of FDG-PET/CT for optimization of radiotherapy planning.

[1]  Karin Haustermans,et al.  Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  C. Rübe,et al.  Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  Akram Al-Ibraheem,et al.  Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review. , 2011, Hematology/oncology and stem cell therapy.

[4]  S. Marnitz,et al.  Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy , 2006, Clinical Cancer Research.

[5]  Cyrill Burger,et al.  Automated functional image-guided radiation treatment planning for rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[6]  F. Mottaghy,et al.  Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost , 2012, Radiation Oncology.

[7]  Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome , 2011, Radiation oncology.

[8]  K. Carson,et al.  F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY – BASED RADIOTHERAPY TARGET VOLUME DEFINITION IN NON – SMALL-CELL LUNG CANCER : DELINEATION BY RADIATION ONCOLOGISTS VS . JOINT OUTLINING WITH A PET RADIOLOGIST ? , 2022 .

[9]  Robert Jeraj,et al.  PET scans in radiotherapy planning of lung cancer. , 2012, Lung cancer.

[10]  Daniela Thorwarth,et al.  Physical radiotherapy treatment planning based on functional PET/CT data. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  C. Onal,et al.  Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy , 2012, Radiation oncology.

[12]  Giuseppe Lucio Cascini,et al.  Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). , 2007, Lung cancer.

[13]  M. Hasegawa,et al.  Phantom study on radiotherapy planning using PET/CT--delineation of GTV by evaluating SUV. , 2010, Journal of radiation research.

[14]  Ronald Boellaard,et al.  Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[16]  S. Macdonald,et al.  PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: A case series , 2011, Radiation oncology.

[17]  Mohamed Allaoua,et al.  Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. , 2004, International journal of radiation oncology, biology, physics.

[18]  Johan Bussink,et al.  PET–CT for radiotherapy treatment planning and response monitoring in solid tumors , 2011, Nature Reviews Clinical Oncology.

[19]  B. Krause,et al.  Curative treatment of oesophageal carcinoma: current options and future developments , 2011, Radiation oncology.

[20]  Robert Jeraj,et al.  Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? , 2012, The Lancet. Oncology.

[21]  C. Belka,et al.  Choline PET based dose-painting in prostate cancer - Modelling of dose effects , 2010, Radiation oncology.

[22]  D. Vriens,et al.  Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review , 2009, Journal of Nuclear Medicine.

[23]  David Binns,et al.  A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Kyung-Ja Cho,et al.  FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. , 2005, International journal of radiation oncology, biology, physics.

[25]  Jean-François Daisne,et al.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.

[26]  Hanna Bernstine,et al.  Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study , 2012, Radiation oncology.

[27]  G. Stoffels,et al.  Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas , 2012, Strahlentherapie und Onkologie.

[28]  L. Gianolli,et al.  PET-guided dose escalation tomotherapy in malignant pleural mesothelioma , 2011, Strahlentherapie und Onkologie.

[29]  H. Zaidi,et al.  Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma , 2012, Radiation oncology.

[30]  Dirk De Ruysscher,et al.  PET scans in radiotherapy planning of lung cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  A. Scarsbrook,et al.  [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review , 2010, Postgraduate Medical Journal.

[32]  D. Zips,et al.  Bio-IGRT , 2010, Nuklearmedizin.

[33]  M. Gregianin,et al.  Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  Cyrill Burger,et al.  Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[35]  K Schnabel,et al.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.

[36]  M. Thakur,et al.  18-Fluoro-Deoxy-Glucose Positron Emission Tomography With Computed Tomography–Based Gross Tumor Volume Estimation and Validation With Magnetic Resonance Imaging for Locally Advanced Cervical Cancers , 2012, International Journal of Gynecologic Cancer.

[37]  F. Fazio,et al.  Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. , 2005, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[38]  Cordula Petersen,et al.  [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes , 2011, Radiation oncology.

[39]  M. Dietlein,et al.  Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma , 2010, Leukemia & lymphoma.

[40]  T. Hany,et al.  3D-Segmentation of the 18F-choline PET Signal for Target Volume Definition in Radiation Therapy of the Prostate , 2007, Technology in cancer research & treatment.

[41]  D. de Ruysscher PET-CT in radiotherapy for lung cancer. , 2011, Methods in molecular biology.